Tweetovi

Blokirali ste korisnika/cu @CancerConnector

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @CancerConnector

  1. Prikvačeni tweet
    14. sij

    (TWEETORIAL - THREAD) Psyched to share new results. New : Optimizing Clinical Outcome and Toxicity in Lung Cancer Using a Genomic Marker of Radiosensitivity (1/7)

    Prikaži ovu nit
    Poništi
  2. proslijedio/la je Tweet
    prije 10 sati

    Motor proteins have always fascinated me. I have showed students videos of dynein and kinesin transporting goods each of the times I’ve TA’d. A beautiful example of the universe within.

    Poništi
  3. proslijedio/la je Tweet
    Poništi
  4. proslijedio/la je Tweet

    A full lineup of colloquia, workshops and seminars begin today . Free and open to all! Registration required for Wednesday's Quantum Meetup & Workshop Happy Hour Join us!

    Poništi
  5. proslijedio/la je Tweet

    Teaching microbial ecol/evol & considering going full nCoV for a while. I feel like its almost irresponsible to not mention. It is, of course, also irresponsible to focus on disease @ the expense of other important ecol/evol topics. But the learning opps are so rich. Thoughts?

    Poništi
  6. proslijedio/la je Tweet
    2. velj

    Our labs inaugural just posted! We build a humanized immunoPET to quantitatively visualize Glypican-3 (GPC3), an important biomarker for hepatocellular carcinoma in multiple models of . Could help with selection for GPC3-directed therapies!

    Prikaži ovu nit
    Poništi
  7. proslijedio/la je Tweet
    3. velj

    Our new work on the stepping dynamics of the motor protein myosin V has just come out in (uncannily accurate illustration below courtesy of the Eindhoven silly walks tunnel): (1/4)

    Prikaži ovu nit
    Poništi
  8. proslijedio/la je Tweet
    3. velj
    Poništi
  9. proslijedio/la je Tweet
    2. velj

    Apparently not specified in the original Vancouver documents (), so subject to variability. Some subtleties with MLA and quotations (). APA appears to be before and legal Bluebook has citation sentences after.

    Poništi
  10. proslijedio/la je Tweet

    Depends on the citation style. Superscript after the period, parenthetical before the period.

    Poništi
  11. proslijedio/la je Tweet
    2. velj

    Aahhh I struggle with this too! If ref in brackets [] I like before but for superscript I prefer after! Sometimes reviewers will reverse whatever decision I made...is there a right answer?

    Poništi
  12. 2. velj
    Poništi
  13. 2. velj

    so and I are quietly and politely wrestling in an doc. which is it? period before the reference, or period after the reference?

    Poništi
  14. proslijedio/la je Tweet
    2. velj

    I wrote R code to perform multiple randomization tests each with 1 million trials. I started the analysis last night ~11pm and it's still going 13 hours later. However, I'm not sure if it froze along the way. Is it possible to show progress in the R console?

    Poništi
  15. proslijedio/la je Tweet
    1. velj

    Types of peer review: 1) 3 anonymous scientists write secret reviews in a process that takes a few months 2) dozens of known experts write comments that anyone in the world can see hours after a paper is posted (e.g this thread 👇) Explain to me again why is 1 >> 2?

    Poništi
  16. proslijedio/la je Tweet
    1. velj

    I don’t understand the attack on preprints (because of the “virus is engineered” MS). *Owing* to the preprint the problems were identified & it didn’t reach the public. Someone forgot that “vaccines cause autism” was published in the Lancet? (Retracted after many years of damage)

    Poništi
  17. proslijedio/la je Tweet
    1. velj

    Spending my Saturday learning about micro aggressions.

    Poništi
  18. 1. velj

    Great cause! These grants support (among other things) clinicians to go back for basic science PhDs to drive translational questions in cancer - funded ‘s own !!

    Poništi
  19. proslijedio/la je Tweet
    1. velj

    Please support !!! We are a team of scientists/ clinicians ( & Clare Pacini) taking part in ❄️❄️❄️ in on 9 Feb. Please help us fundraise for 😀🏅

    , , i još njih 3
    Prikaži ovu nit
    Poništi
  20. proslijedio/la je Tweet
    30. sij

    Nice work by et al to validate the NCCN intermediate risk prostate cancer stratification (favorable vs. unfavorable) in >1500 LDR brachytherapy patients:

    Poništi
  21. proslijedio/la je Tweet
    30. sij

    The bipolar nature of grant writing. Each cycle lasts ~24 hours: 1. Holy crap this grant is amazing! I’m going to cure cancer!! Pure happiness. 2. This is quite possibly the worst grant ever written. I’m going to have to work at Starbucks. ... and repeat

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·